On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayMay 31, 2022 12:45 pm

Social Media & Influencer Strategies Summit to Cover All Aspects of Social Media Marketing and Influencer Marketing Strategies

The Social Media & Influencer Strategies Summit promises to bridge the “best of both worlds,” conflating two conferences set to be held over four days. Organized by GSMI Events, the virtual event scheduled for June 7-10 includes a two-day Social Media Summit set for June 7 and 8, in which the speakers and panelists will focus their talks on social media marketing and content strategy, and an Influencer Summit subsequently slated for June 9 and 10. The latter will feature influencer-marketing-focused case studies and talks delivered by leading figures in the influencer segment. Attendees will get to hear from 50…

Continue Reading

TuesdayMay 31, 2022 12:00 pm

CWCBExpo, the Premier B2B Cannabis, and Hemp Expo and Conference to Foster Lively Discussion on Industry Opportunities and Challenges Among Seasoned Professionals and Newcomers Alike

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held between June 2-4, 2022, at the Javits Convention Center, Hall 3A, in New York City. Industry heavyweights, the foremost innovators, and pioneering thought leaders will take the stage to discuss emerging trends in cannabis, hemp, and allied sectors. The expo will provide a high-quality business-focused attendee base located in the premier East Coast US cannabis and hemp market.  The three-day event will feature an Inside the Industry: Thought Leadership Series in an interactive “Talk Show” format. Co-hosts will include Carl Cameron, veteran journalist and former FOX News reporter; Faye…

Continue Reading

TuesdayMay 31, 2022 11:15 am

Silo Pharma Inc. (SILO) Focuses on Psilocybin’s Anti-Inflammatory Properties

On May 19, 2022, Silo Pharma (OTCQB: SILO) announced that The Translational Psychedelic Research (“TrPR”) Program at UCSF (University of California San Francisco) had “successfully dosed [with psilocybin] patients suffering from Parkinson’s disease.” TrPR connects researchers and medical professionals studying how psychedelics, including psilocybin, ketamine, etc., affect brain functions and other organ systems. Silo Pharma focuses on palliative uses of psychedelics for “PTSD, Parkinson’s, and other rare neurological disorders.” In teaming up with TrPR. Silo is exploring psilocybin’s anti-inflammatory possibilities in patients exhibiting signs of Parkinson’s Disease.  Psilocybin’s journey from magic mushrooms to potential life savers has been a long,…

Continue Reading

TuesdayMay 31, 2022 10:30 am

Mullen Automotive Inc. (NASDAQ: MULN) Working to Alleviate Consumer Anxiety by Offering EVs with 600-Plus Mile Range

J.D. Power survey reports range was factor most cited in deciding what EV to buy Mullen is making significant strides toward producing vehicles that feature some of the longest ranges available in the EV space Recognizing the critical role of battery and range in the success of an EV, Mullen is exploring other advanced battery technologies One of the challenges preventing enthusiastic acceptance of electric vehicles is range anxiety, fear that an electric car will run out of battery or fuel before the driver can reach their destination or a charging station. The concern is valid — a January 2022…

Continue Reading

TuesdayMay 31, 2022 9:45 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) and Kernel Report Result of Study Measuring Ketamine’s Effects on the Brain

Study shows that COVID-19 pandemic has affected mental health of 59% of U.S. population, intensifying already-serious issue CYBN-sponsored feasibility study indicates ketamine-induced changes in brain’s functional connectivity persisted for several days after receiving the substance Kernel Flow pivotal in developing most accurate, effective treatment regimens for patients The challenges associated with mental-health issues are rising, following the global pandemic. Already a serious problem before COVID-19, mental health has become even more pressing now, with many companies committed to offering relief to the nearly 1 billion people worldwide who deal with mental-health issues. Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical…

Continue Reading

TuesdayMay 31, 2022 9:00 am

Odyssey Group International Inc. (ODYY) Is ‘One to Watch’

Odyssey boasts a diverse development portfolio spanning both pharmaceutical candidates and medical devices The company is evaluating PRV-002 for the treatment of concussion, a dramatically underserved indication that currently has no FDA-approved drug With PRV-001, Odyssey aims to receive Orphan Drug designation, which could potentially accelerate its pathway to FDA approval and provide seven years of market exclusivity CardioMap(R) is intended to provide early, non-invasive testing for heart disease and is being developed for a 510(k) regulatory pathway Save-A-Life is a developmental anti-choking device that Odyssey expects to position as the “accepted” standard and leader in the treatment of choking…

Continue Reading

FridayMay 27, 2022 12:00 pm

Crypto Enthusiasts to Gather in Austin, TX for Four-Day 2022 Consensus Festival, Featuring Everything from Blockchain to Web3

Hosted by CoinDesk, the 2022 Consensus festival is slated for June 9-12, 2022, in Austin, Texas The festival features 15,000+ attendees, 400+ speakers, and 250+ event sponsors, catering to all sides of blockchain, crypto, Web3, NFTs and the Metaverse Web3 is the future of the internet – creating a decentralized technology that removes the control from the big tech companies and places it back in the hands of the users Venture Capitalist firm Andreessen Horowitz announced a $4.5 billion fund aimed at Web3; with one third of the funds dedicated exclusively to seed deals Coinbase has become the first crypto-based…

Continue Reading

FridayMay 27, 2022 11:15 am

Nowigence Inc. (NOWG) Knowledge Management Tool Distinguishes Itself by Offering Ability to Gather, Organize and Communicate Data

A key to becoming “irreplaceable” is to communicate clearly, Inc. article suggests Nowigence believes the capability to communicate clearly can be found in its high-proprietary, cloud-based knowledge management tool: Pluaris Pluaris reads and analyzes information across the internet 24/7, then organizes and optimizes gathered data for storage, analysis, synthesis and retrieval As companies — and individuals — work to make themselves irreplaceable, an Inc. newsletter notes that communicating clearly is a key skill (https://ibn.fm/0863V). Nowigence’s Inc. (NOWG) Pluaris, a high-proprietary, cloud-based knowledge management tool, makes clear communication easier than ever before. One solution, the article points out, is to distinguish…

Continue Reading

FridayMay 27, 2022 10:30 am

Kronos Advanced Technologies Inc. (KNOS) Closes on Milestone Acquisition, Moves Forward with American-Made Manufacturing Plan

Acquisition of 85,000-square-foot West Virginia manufacturing campus is key milestone in company’s vision to become household name Facility checks all boxes company wanted in first design and manufacturing location Kronos is focused on designing and manufacturing next-generation wellness consumer electronics products and PPE solutions A plan started more than two years ago by Kronos Advanced Technologies (OTC: KNOS) is a step closer to fruition today; the company recently announced closed on the acquisition of an 85,000-square-foot West Virginia manufacturing campus that will be retrofitted to produce advanced, proprietary air-purification devices and other wellness products (https://ibn.fm/FQS30). “Nearly two years ago, we…

Continue Reading

FridayMay 27, 2022 9:45 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Poised to Capitalize on Opportunities for Sustainable Investing Amid Growing RNG Market

Legislative changes driven by public policy commitment to slashing greenhouse emissions are driving increased demand for renewable natural gas (“RNG”) RNG generation avoids toxic emissions of methane, a greenhouse gas with a warming potential 25–34 times greater than Carbon Dioxide EverGen, Canada’s established renewable natural gas producer, appears ready to act on this rising market opportunity in Canada and beyond; responds with plans to consolidate projects, enter merger, and acquisition transactions, and grow core portfolio projects "We set up EverGen to execute on space that has a tremendous amount of tailwind”, are the words Chase Edgelow, co-founder and CEO of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered